Literature DB >> 35258680

Molecular Characterization and Antibiotic Susceptibility Profile of Acinetobacter baumannii Recovered from Hospital Wastewater Effluents.

Qaqamba Mapipa1,2, Tennison Onoriode Digban1,2, Nonso Emmanuel Nnolim1,2, Nolonwabo Nontongana1,2, Anthony Ifeanyi Okoh1,2,3, Uchechukwu U Nwodo4,5.   

Abstract

Acinetobacter baumannii (A. baumannii) plays a significant part in nosocomial infections world over and is re-emerging as a formidable pathogen due to the wide range of antibiotic resistance factors it acquires and environmental resilience. The high attendance of patients (outpatients and inpatients) into the health care facilities formed the basis for the selection of the hospitals. Consequently, this study profiled the antibiogram and antibiotic resistance genes of A. baumannii isolated from selected hospital wastewater effluents. A total of twenty-four (24) wastewater samples from three selected hospital drainages were collected and analysed presumptively by culture-dependent methods for A. baumannii. The identity confirmation of A. baumannii was done by the amplification of recA and blaoxa-51 genes. Virulence and antibiotic resistance markers were assessed using polymerase chain reaction. A total of 53 A. baumannii isolates were confirmed and the highest antibiotic resistance profile was 93% (piperacillin). Multiple antibiotic resistance index (MARI) showed a range of 0.23 and 0.46. FimH virulence gene was detected in 29 (55%) of the isolates. Tetracycline and beta-lactam resistance markers were found; 70% and 92% of the isolates possessed tetA and ampC genes. The isolates showed high level of resistance to antibiotics. The multiple antibiotic resistance index (MARI) of ≥ 0.2 indicates that some of the isolates harbour virulence and resistance traits emerging from high-risk source thereby projecting a threat to public health.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35258680     DOI: 10.1007/s00284-022-02815-7

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  43 in total

Review 1.  The epidemiology and control of Acinetobacter baumannii in health care facilities.

Authors:  Pierre Edouard Fournier; Hervé Richet
Journal:  Clin Infect Dis       Date:  2006-01-26       Impact factor: 9.079

Review 2.  Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis.

Authors:  Carina Dexter; Gerald L Murray; Ian T Paulsen; Anton Y Peleg
Journal:  Expert Rev Anti Infect Ther       Date:  2015-05       Impact factor: 5.091

3.  Nursing Home as a Reservoir of Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Branka Bedenić; Nataša Beader; Karmen Godič-Torkar; Mirna Vranić-Ladavac; Josefa Luxner; Zoran Veir; Andrea J Grisold; Gernot Zarfel
Journal:  Microb Drug Resist       Date:  2015-01-19       Impact factor: 3.431

Review 4.  Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside.

Authors:  Ming-Feng Lin; Chung-Yu Lan
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

Review 5.  Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.

Authors:  J Alexander Viehman; M Hong Nguyen; Yohei Doi
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

Review 6.  Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections.

Authors:  Matthieu Eveillard; Marie Kempf; Olivier Belmonte; Hélène Pailhoriès; Marie-Laure Joly-Guillou
Journal:  Int J Infect Dis       Date:  2013-05-11       Impact factor: 3.623

Review 7.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 8.  Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models.

Authors:  Michael J McConnell; Luis Actis; Jerónimo Pachón
Journal:  FEMS Microbiol Rev       Date:  2012-06-18       Impact factor: 16.408

9.  VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France.

Authors:  Thierry Naas; Bruno Coignard; Anne Carbonne; Karine Blanckaert; Odile Bajolet; Claude Bernet; Xavier Verdeil; Pascal Astagneau; Jean-Claude Desenclos; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2006-08       Impact factor: 6.883

Review 10.  Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.

Authors:  Chang-Ro Lee; Jung Hun Lee; Moonhee Park; Kwang Seung Park; Il Kwon Bae; Young Bae Kim; Chang-Jun Cha; Byeong Chul Jeong; Sang Hee Lee
Journal:  Front Cell Infect Microbiol       Date:  2017-03-13       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.